Advertisement

Topics

TPI Enterprises buys Vistin opiates assets and confirms Portugal plant plan

12:30 EDT 21 Jul 2017 | in-PharmaTechnologis

TPI Enterprises has bought Vistin Pharma ASA’s opiates and tabletting division for A$25.4m ($201.m) in a deal designed to expand the firm beyond its narcotic raw materials business.

Original Article: TPI Enterprises buys Vistin opiates assets and confirms Portugal plant plan

NEXT ARTICLE

More From BioPortfolio on "TPI Enterprises buys Vistin opiates assets and confirms Portugal plant plan"

Quick Search
Advertisement